English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/189019
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment

AuthorsLópez-Hurtado, Alejandro; Peraza, Diego A.; Cercós, Pilar ; Lagartera, Laura ; González Pérez, Paz; Dopazo, Xose M.; Herranz, Rosario ; González, Teresa ; Martín-Martínez, Mercedes ; Mellström, Britt; Naranjo, José Ramón; Valenzuela, Carmen ; Gutiérrez-Rodríguez, Marta
Issue Date2019
PublisherSpringer Nature
CitationScientific Reports 9: 7260 (2019)
AbstractDREAM, a neuronal calcium sensor protein, has multiple cellular roles including the regulation of Ca2+ and protein homeostasis. We recently showed that reduced DREAM expression or blockade of DREAM activity by repaglinide is neuroprotective in Huntington's disease (HD). Here we used structure-based drug design to guide the identification of IQM-PC330, which was more potent and had longer lasting effects than repaglinide to inhibit DREAM in cellular and in vivo HD models. We disclosed and validated an unexplored ligand binding site, showing Tyr118 and Tyr130 as critical residues for binding and modulation of DREAM activity. IQM-PC330 binding de-repressed c-fos gene expression, silenced the DREAM effect on KV4.3 channel gating and blocked the ATF6/DREAM interaction. Our results validate DREAM as a valuable target and propose more effective molecules for HD treatment.
Publisher version (URL)https://doi.org/10.1038/s41598-019-43677-7
Appears in Collections:(IIBM) Artículos
(IQM) Artículos
(CNB) Artículos
Files in This Item:
File Description SizeFormat 
targetdise.pdf3,89 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.